The purchases reported on this Form 4 represent shares of Common Stock purchased by the Reporting Person.

This transaction was executed in multiple trades at prices ranging from $6.69  to $6.90. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This number reflects the aggregate amount of Common Stock held by the reporting person.

This transaction was executed in multiple trades at prices ranging from $6.15  to $6.39. The price reported above reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/ James Stillman Hanson, Attorney-in-Fact for Peter M. Neupert


Class B Common Stock

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class B Common Stock.

The restricted stock units vest on the earlier of the first anniversary of the grant date or the date of the first annual meeting of stockholders following the grant date.

/s/ Stephanie Kyoko McKinnon, Attorney-in-Fact


Class B Common Stock

On August 7, 2025 (the "Closing Date"), the previously announced transactions contemplated by the transaction agreement (the "Transaction Agreement"), dated as of July 7, 2024, by and among Skydance Media, LLC ("Skydance"), Paramount Global ("Old Paramount"), New Pluto Global, Inc. ("New Paramount"), and the other parties thereto, were completed. Pursuant to the terms of the Transaction Agreement, in a series of transactions, among other things, (i) each of Old Paramount and Skydance merged into subsidiaries of New Paramount; (ii) each share of Old Paramount Class A Common Stock automatically converted into the right to receive one share of Class A Common Stock of New Paramount and (iii) each share of Old Paramount Class B Common Stock automatically converted into the right to receive one share of Class B Common Stock of New Paramount (the "Transactions"). In connection with the closing of the Transactions, New Paramount changed its name to Paramount Skydance Corporation (the "Issuer")

By Skydance Entertainment Group, LLC, of which Mr Ellison is the manager.

The restricted stock units vest quarterly over a 5-year period commencing on the Closing Date.


Class B Common Stock

The restricted stock units vest on the earlier of the first anniversary of the grant date or the date of the first annual meeting of stockholders following the grant date..


Class B Common Stock


Class B Common Stock

The restricted stock units vest quarterly over a 5-year period commencing on August 7, 2025.


Class B Common Stock

Class B Common Stock

On July 30, 2025, pursuant to the terms and conditions of the Assignment Agreement, dated as of July 30, 2025, by and between RB Tentpole LP and RB Tentpole Holdings LP, RB Tentpole LP assigned its rights under the Subscription Agreement (as amended, the "Subscription Agreement"), dated as of July 7, 2024, by and among Paramount Global ("Old Paramount"), New Pluto Global, Inc. ("New Paramount") and RB Tentpole LP, to RB Tentpole Holdings LP. On August 7, 2025 (the "Closing Date"), the previously announced private placement investment contemplated by the Subscription Agreement was completed. Pursuant to the terms of the Subscription Agreement, RB Tentpole Holdings LP acquired 83,640,992 shares of the Class B Common Stock of New Paramount ("Class B Common Stock") and warrants to acquire 45,000,000 shares of Class B Common Stock in exchange for aggregate consideration of $1,254,614,880 (the "PIPE Purchase").

In connection with the foregoing and the closing of the Transactions (as defined below), New Paramount changed its name to Paramount Skydance Corporation (the "Issuer").

The shares of Class B Common Stock and warrants to acquire shares of Class B Common Stock acquired in connection with the PIPE Purchase are held directly by RB Tentpole Holdings LP. Mr. Cardinale is the sole limited partner of and the sole member of the general partner of RedBird Capital Partners L.P. RedBird Capital Partners L.P. is the general partner of RedBird Holdings Carry Vehicle LP, which is a member of RedBird Capital Partners Holdings LLC. RedBird Capital Partners Holdings LLC is the sole member of RB Tentpole GenPar LLC, which is the general partner of RB Tentpole Holdings LP. Mr. Cardinale also indirectly owns a limited partner interest in RB Tentpole LP, the sole member of RB Tentpole Holdings LP.

As a result of the aforementioned relationships in Footnote 3, Mr. Cardinale may be deemed to share beneficial ownership of the securities directly and indirectly beneficially owned by RB Tentpole Holdings LP. Mr. Cardinale disclaims beneficial ownership of those securities except to the extent of any pecuniary interest therein.

Certain shares of the Class B Common Stock of the Issuer may be distributed to indirect investors in RB Tentpole Holdings LP at such times as they request pursuant to contractual arrangements to which such investors are party and Mr. Cardinale expects to report such distributions on Form 4 if and when such distributions are made.

RB Tentpole Holdings LP owns approximately 22.5% of the common stock of Harbor Lights Entertainment, Inc. ("HLE"), which, as of the date hereof, directly and through wholly owned subsidiaries, HLE holds shares of Class B Common Stock and shares of Class A Common Stock of the Issuer. Each share of Class A Common Stock is convertible into 1.5 shares of Class B Common Stock. Mr. Cardinale disclaims beneficial ownership of those securities, however, on the basis that RB Tentpole Holdings LP does not control HLE or HLE's investment portfolio.

On the Closing Date, the previously announced transactions contemplated by the Transaction Agreement (the "Transaction Agreement"), dated as of July 7, 2024, by and among Skydance Media, LLC ("Skydance"), Old Paramount, New Paramount, and the other parties thereto, were completed. Pursuant to the terms of the Transaction Agreement, in a series of transactions, among other things, (i) each of Old Paramount and Skydance merged into subsidiaries of New Paramount, (ii) each share of Old Paramount Class A Common Stock automatically converted into the right to receive one share of Class A Common Stock of New Paramount and (iii) each share of Old Paramount Class B Common Stock automatically converted into the right to receive one share of Class B Common Stock (the "Transactions").

These shares of Class B Common Stock acquired in connection with the Transactions are held directly by RB Maverick LLC and include 9,614,911 shares of Class B Common Stock acquired by RB SKD AIV B, LP and contributed in kind to RB Maverick LLC on the Closing Date. Mr. Cardinale is the sole limited partner of and the sole member of the general partner of RedBird Capital Partners L.P. RedBird Capital Partners L.P. is the general partner of RedBird Holdings Carry Vehicle LP, which is a member of RedBird Capital Partners Holdings LLC. RedBird Capital Partners Holdings LLC is the sole member of RedBird Series 2019 Carry Vehicles LLC, which is the sole member of RedBird Series 2019 GenPar LLC. RedBird Series 2019 GenPar LLC is the general partner of RB SKD AIV UB, LP, which owns a limited liability company interest in RB SKD Borrower LLC. RB SKD Borrower LLC is the sole member of RB Maverick LLC.

Mr. Cardinale also indirectly owns a limited liability company interest in RB SKD Borrower LLC, the sole member of RB Maverick LLC. As a result of the aforementioned relationships in Footnote 8, Mr. Cardinale may be deemed to share beneficial ownership of the securities directly and indirectly beneficially owned by RB Maverick LLC. Mr. Cardinale disclaims beneficial ownership of those securities except to the extent of any pecuniary interest therein.

The exercise price and number of underlying shares of Class B Common Stock of each warrant are subject to anti-dilution adjustments pursuant to the Warrant Agreement, dated as of August 7, 2025 (the "Warrant Agreement"), by and between RB Tentpole Holdings LP and the Issuer, as filed with the Securities and Exchange Commission on August 7, 2025.

Pursuant to a contractual incentive arrangement between RedBird Tentpole Warrants, L.P. and RB Tentpole LP, RedBird Tentpole Warrants, L.P. is entitled to receive a portion of the 45,000,000 warrants to purchase Class B Common Stock currently directly held by RB Tentpole Holdings LP if and when the market price of the Class B Common Stock exceeds $30.50 per share at market close, subject to certain adjustments described in the Warrant Agreement.

Each restricted stock unit represents a contingent right to receive one share of the Issuer's Class B Common Stock.

The restricted stock units vest on the earlier of the first anniversary of the grant date or the date of the first annual meeting of stockholders following the grant date.


Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $12.56 to $13.555. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.

Represents a weighted average sales price per share. These shares were sold in multiple transactions at prices ranging from $13.56 to $14.17. The Reporting Person has provided to the Issuer, and undertakes to provide to the staff of the Securities and Exchange Commission or any security holder of the Issuer, upon request, full information regarding the number of shares sold at each separate price within the range.


THE SALES REPORTED IN THIS FORM 4 WERE EFFECTED PURSUANT TO A RULE 10b5-1 TRADING PLAN.

The price reported in Column 4 is a weighted average price.  These shares were sold in multiple transactions at prices ranging from $18.06 to $18.22, inclusive.  The reporting person undertakes to provide to Alexander & Baldwin, Inc., any security holder or Alexander & Baldwin, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Non-Qualified Stock Option (right to buy)

Common Stock

Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant.

By: Sharon O'Connor For: Jeffrey Michael


Common Stock

Each restricted stock unit (RSU) represents the contingent right to receive one share of common stock of the Issuer upon vesting of the RSU.

These RSUs were granted on April 29,  2025 and will vest in full on the earlier of the first anniversary of the grant date of the date of the next annual meeting of stockholders following the date of grant.


Common Stock

The options were granted under the 2025 Second Supplemental Option Plan of the Issuer. The options vested immediately, but are not exercisable until stockholder approval of the 2025 Second Supplemental Option Plan is received. If stockholder approval is not received prior to August 8, 2026, the options will be cancelled.

Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as a director of the Issuer.


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $172.50 to $173.50 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Includes 2,351 shares to be issued in connection with the vesting of restricted stock units. The Reporting Person shares pecuniary interest in such shares with other parties pursuant to contractual relationships. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest in these shares.

Shares held by a limited partnership of which the Reporting Person is a trustee of a trust which is the general partner. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $173.515 to $174.405 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $175.07 to $175.86 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares held by an irrevocable trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

Shares held by a trust of which the Reporting Person is a Trustee. The Reporting Person disclaims beneficial ownership in these shares except as to the Reporting Person's pecuniary interest therein.

/s/ Kanwalpreet S. Kalra, Attorney-in-Fact


Common Stock


The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on September 10, 2024.

/s/ Philip Reuther, as attorney-in-fact for Bruce Ledesma


Through Blair Jordan Strategy and Finance Consulting Inc.

Common Stock

Mr. Jordan owns and controls Blair Jordan Strategy and Finance Consulting Inc. and as such is deemed to beneficially own the securities held by such entity.

On February 5, 2025, the Issuer, the Reporting Person and Dr. James Woody, entered into a Voting Agreement, whereby Dr. Woody agreed to vote a total of 43,166 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to February 5, 2026, the date after August 5, 2025, that Dr. Woody has sold all of the shares or the date that the Issuer terminates the Voting Agreement. In order to enforce the terms of the Voting Agreement, Dr. Woody provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 43,166 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders.

As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 43,166 shares of common stock of the Issuer held by Dr. Woody. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein.

On February 21, 2025, the Issuer, the Reporting Person and Dr. Marlene Krauss, entered into a Voting Agreement, whereby Dr. Krauss agreed to vote a total of 200,000 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to August 21, 2025. In order to enforce the terms of the Voting Agreement, Dr. Krauss provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 200,000 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders.

As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 200,000 shares of common stock of the Issuer held by Dr. Krauss. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein.

On April 28, 2025, the Issuer, the Reporting Person and Elray Resources, Inc. ("Elray") entered into a Voting Agreement, whereby Elray agreed to vote a total of 1,318,000 shares of the Issuer's common stock, as recommended by the Board of Directors of the Issuer, at any meeting of stockholders or via any written consent of stockholders, which may occur prior to April 28, 2026. In order to enforce the terms of the Voting Agreement, Elray provided the Reporting Person (or his assigns), solely for the benefit of the Issuer, an irrevocable voting proxy to vote the 1,318,000 shares pursuant to the guidelines set forth above at any meeting of stockholders or via any written consent of stockholders.

As a result of the irrevocable voting proxy, Mr. Jordan may be deemed to beneficially own the 1,318,000 shares of common stock of the Issuer held by Elray. Except for the limited right to vote such shares pursuant to the Voting Agreement, Mr. Jordan has no dispositive control over the shares, nor any pecuniary interest therein.

The options were granted under the 2025 Second Supplemental Option Plan of the Issuer. The options vested immediately, but are not exercisable until stockholder approval of the 2025 Second Supplemental Option Plan is received. If stockholder approval is not received prior to August 8, 2026, the options will be cancelled.

Issued to the Reporting Person in consideration for services rendered and agreed to be rendered to the Issuer as an officer of the Issuer.


Held in trust pursuant to the Employee Stock Ownership Plan.

Total includes the reinvestment of dividends.

/s/ W. Eric Marr, as Attorney-In-Fact for Vincent Sorgi


Common Stock

The exercise, sale, and gift were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 28, 2025.

Includes shares to be issued in connection with the vesting of one or more restricted stock units.

The shares are held by The Snow Trust UTA dated 9/10/19 for which the Reporting Person is a trustee.

The shares are held by The Thira GRAT No. 1 dated 3/13/2025 for which the Reporting Person's spouse is the trustee. The Reporting Person has no right to or interest in these shares and disclaims beneficial ownership of these shares.

The shares are held by The Selene GRAT No. 1 dated 3/13/2025 for which the Reporting Person is the trustee.

The stock option is fully vested.


This transaction was executed in multiple trades ranging from $1.73 to $1.82 per share. The price reported above reflects the weighted average per share sales price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the issuer or security holder of the issuer, full information regarding the number shares purchased at each separate price.


The sale of shares was effected pursuant to a Rule 10b5-1 trading plan entered into by the reporting person for the benefit of the reporting person's relatives on December 13, 2024.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $139.50 to $140.495, inclusive. The reporting person undertakes to provide Arista Networks, Inc., any security holder of Arista Networks, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These shares are held in trust for the benefit of the children of the reporting person for which the reporting person serves as trustee. The reporting person shares voting and investment control over the shares but disclaims beneficial ownership of the shares.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $140.50 to $141.00, inclusive. The reporting person undertakes to provide Arista Networks, Inc., any security holder of Arista Networks, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The exercises and/or sales reported on this Form 4 were made pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 13, 2024.

These shares are held by a family trust for which the reporting person is co-trustee.

These shares are held in trust for the benefit of relatives of the reporting person for which the reporting person serves as co-trustee.  The reporting person shares voting and investment control over the shares but disclaims beneficial ownership of the shares.

By: Isabelle Bertin-Bailly, Attorney-in-Fact For: Jayshree Ullal


The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $186.1125 to $187.015, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $186.155 to $188.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $188.17 to $188.90, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $184.20 to $185.09, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $185.215 to $186.915, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $186.20 to $187.10, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $187.23 to $188.055, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within such range.

Delia J. Makhlouta, by power of attorney


Common Stock

1/48th of the shares subject to such option shall vest and become exercisable in substantially equal monthly installments on each monthly anniversary of August 1, 2025, subject to the Reporting Person's continuous service to the Issuer on each such date.


Common Stock

2/48th of the shares subject to such option shall vest and become exercisable on October 1, 2025 and the remaining shares subject to the option shall vest in 46 substantially equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.


Common Stock

Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant.


Common Stock

6/48th of the shares subject to such option shall vest and become exercisable on February 1, 2026 and the remaining shares subject to the option shall vest in 42 substantially equal monthly installments on each monthly anniversary thereafter, subject to the Reporting Person's continuous service to the Issuer on each such date.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

The option vests on the earlier of the one year anniversary of the grant date (10/24/2024) or the date of Bio-Techne's 2025 annual meeting of shareholders.

/s/ Andrew Nick as Attorney-in-Fact for John L. Higgins pursuant to Power of Attorney previously filed


This transaction was executed in multiple trades at prices ranging from $96.00 to $96.05. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Reflects transfers of shares between trusts.

This transaction was executed in multiple trades at prices ranging from $96.51 to $96.70. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

This transaction was executed in multiple trades at prices ranging from $96.59 to $96.99. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.


Shares held by an entity or entities in which the reporting person retains investment power over such shares. Reflects the distribution of 1,148,950 shares transferred from an entity or entities in which the reporting person retains investment power over such shares to the reporting person as an annuity payment on June 19, 2025.

The sales reported were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 5, 2024.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $7.71 to $7.93 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Represents a charitable gift by the reporting person.

Shares held by an irrevocable trust over which the reporting person acts as trustee and has voting power, but has no financial interest. The beneficiaries of the irrevocable trust are not immediate family members of the reporting person.


Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. 100% of the RSUs shall vest after the reporting person completes one year of continuous service from August 2, 2025. The RSUs will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the RSUs will be deemed fully vested immediately. The settlement of such RSUs will be deferred until the earlier of a) the 90th day following the reporting person's separation from service from the Issuer (as defined under Treasury Regulations Section 1.409A-1(h)) or b) a change in control.


Represents shares issuable on settlement of restricted stock units ("RSUs") granted to the reporting person. Each RSU represents a contingent right to receive one share of Issuer's Class A Common Stock. 100% of the RSUs shall vest after the reporting person completes one year of continuous service from August 2, 2025. The RSUs will be subject to pro-rata acceleration upon the reporting person's discontinued service on the Issuer's board of directors and automatic full acceleration in the event of a change in control, as defined in the Issuer's 2017 Equity Incentive Plan. If the reporting person dies while in continuous service, 100% of the RSUs will be deemed fully vested immediately.


Includes 300,133 shares held by certain immediate family members of the reporting person for which the reporting person disclaims beneficial ownership except as to the reporting person's indirect pecuniary interest therein, if any. The remaining shares are held by an entity or entities in which the reporting person acts as trustee and the reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.

The reporting person is trustee of Lynton Foundation. The reporting person disclaims beneficial ownership in these shares except as to the reporting person's pecuniary interest therein.


Sales made pursuant to a 10(b)5-1 trading plan previously adopted by the Reporting Person on December 13, 2024.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $300.27 to $300.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $301.77 to $301.98, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $303.76 to $304.60, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $305.90 to $306.87, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $309.82 to $310.21, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $312.39 to $313.04, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $300.29 to $300.74, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $301.53 to $301.96, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $309.84 to $310.18, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $300.35 to $300.92, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These Class A Shares are held by a pension trust of which the Reporting Person is the sole trustee and who, in that capacity, possesses sole voting and sole dispositive power over these Class A Shares. However, the Reporting Person does not possess any pecuniary interest in these Class A Shares.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $301.49 to $301.54, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

This price reflects the weighted average price at which these shares were sold. The shares were sold in multiple transactions at prices ranging from $309.70 to $309.99, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

These Class A Shares are owned by IGSB Cardinal I, LLC, a limited liability company, of which the Reporting Person is the managing member.  In that capacity, the Reporting Person possesses sole voting and dispositive power over these Class A Shares. However, the Reporting Person disclaims beneficial ownership in these Class A Shares, except to the extent of any pecuniary interest he may have therein.

These Class A Shares are owned by IGSB Gaucho Fund I, LLC, a limited liability company, of which the Reporting Person is the managing member. In that capacity, the Reporting Person possesses sole voting and dispositive power over these Class A Shares. However, the Reporting Person disclaims beneficial ownership in these Class A Shares, except to the extent of any pecuniary interest he may have therein.

These Class A Shares are owned by IGSB Cardinal Core BV, LLC, a limited liability company, of which the Reporting Person is the managing member. In that capacity, the Reporting Person possesses sole voting and dispositive power over these Class A Shares, but he disclaims beneficial ownership in these Class A Shares, except to the extent of any pecuniary interest he may have therein.

/s/ Kimberly Shea, Attorney-in-Fact for Maurice J. Duca


Common Stock, $0.001 par value per share ("Common Stock")

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $10.31 to $10.88, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

The shares of Common Stock reported herein are held directly by (a) Coliseum Capital Partners, L.P. ("CCP"), an investment limited partnership of which Coliseum Capital, LLC, a Delaware limited liability company ("CC"), is general partner and for which Coliseum Capital Management, LLC, a Delaware limited liability company ("CCM"), serves as investment adviser; and (b) a separate account investment advisory client of CCM (the "Separate Account").

Christopher S. Shackelton ("Shackelton") and Adam Gray ("Gray") are managers of and have an ownership interest in each of CCM and CC. Each of Shackelton, Gray, CCP, the Separate Account, CC and CCM disclaims beneficial ownership of these securities except to the extent of that person's pecuniary interest therein.

The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $11.07 to $11.33, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the SEC, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.

Following the transactions reported herein, CCP directly owned 12,172,013 shares of Common Stock and the Separate Account directly owned  2,758,267 shares of Common Stock.


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted on September 30, 2024 by the Reporting Person and by The Patel / Dong Family Trust Dated August 24, 2017, for which the Reporting Person serves as trustee (the "Patel / Dong Family Trust").

This transaction was executed in multiple trades at prices ranging from $17.78 to $18.73. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.

The shares are held by The Patel / Dong Family Trust.

This transaction was executed in multiple trades at prices ranging from $18.805 to $19.16. The price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide upon request by the staff of the Securities and Exchange Commission, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate sale price.


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on December 6, 2024.

/s/ Tammy Albarran as attorney-in-fact for Nick V. Caldwell


Common Stock

Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant.

By: Sharon O'Connor For: Steven Hamerslag


Shares sold in this transaction were acquired on March 28, 2017 through a private placement with the Registrant. This transaction completes the sale of 14,286 common shares disclosed on Form 144 filed on May 21, 2025

The price shown is the weighted average sale price for the transactions reported on this line. The range of sale prices for the 6,500 shares is from $24.31 to $25.45. The filing person will provide full information regarding the number of shares sold at each separate price upon request from the SEC, or a shareholder of the Registrant


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on November 15, 2024.

The transaction was executed in multiple trades at prices ranging from $259.9900 to $260.9850. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $260.9900 to $261.9300. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $262.0100 to $263.0000. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $263.0700 to $263.6150. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $259.1100 to $260.0650. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $260.2450 to $261.1550. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $261.3000 to $262.2575. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $262.3000 to $263.1300. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $258.1500 to $258.9200. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $259.3100 to $260.3000. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $260.3100 to $261.3000. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The transaction was executed in multiple trades at prices ranging from $261.4900 to $261.7200. The price reported above reflects the weighted average sales price. The reporting person hereby undertakes to provide upon request to the SEC staff, Morningstar or a shareholder of Morningstar full information regarding the number of shares and prices at which the transaction was effected.

The shares are held in grantor retained annuity trusts for the benefit of the reporting person and his children. The reporting person serves as trustee of the grantor retained annuity trusts.

The shares are held in trusts for the benefit of the reporting person's children. The reporting person's spouse is trustee of the trusts.

/s/ Kathleen Peacock, by power of attorney


Automatic sale pursuant to a 10b5-1 Trading Plan adopted by the Reporting Person on October 15, 2024.

By: Winston King, Attorney-in-Fact for Michael George Rosenbaum


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $73.51 to $73.59, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price.


Consists of shares (a) sold to provide funds to satisfy tax obligations of the reporting person or (b) withheld by the Issuer to satisfy the tax withholding obligations of the reporting person, in each case arising in connection with the delivery of shares that were granted under the Apollo Global Management, Inc. 2019 Omnibus Equity Incentive Plan (the "Plan").

Reported amount includes 4,876,126 vested and unvested restricted stock units ("RSUs") granted under the Plan. Each RSU represents the contingent right to receive, in accordance with the issuance schedule set forth in the applicable RSU award agreement, one share of common stock of the Issuer for each vested RSU. The RSUs vest in installments in accordance with the terms of the applicable RSU award agreement, provided the reporting person remains in service through the applicable vesting date.

By Zelter APO Series LLC, a vehicle over which the reporting person exercises voting and investment control.

By The James C. Zelter 2023 GRAT No. 1, a vehicle over which the reporting person exercises voting and investment control.

By The James C. Zelter 2024 GRAT No.1, a vehicle over which the reporting person exercises voting and investment control.

/s/ Jessica L. Lomm, as Attorney-in-Fact


This transaction was executed in multiple trades at prices ranging from $10.19 to $10.33 per share. The reported price reflects the weighted average purchase price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

/s/ Rachel Malina, Attorney-in-Fact for John F. Sheridan


Common Stock

Exercisable in a series of 4 equal and successive annual installments commencing 12 months following the date of grant.


By Chan Zuckerberg Initiative Foundation

Class A Common Stock

Class A Common Stock

By Mark Zuckerberg, Trustee Of The Mark Zuckerberg Trust Dated July 7, 2006

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2025.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $760.03 to $761.01 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $761.05 to $761.785 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $762.09 to $763.04 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $763.17 to $764.155 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $764.275 to $765.12 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $765.45 to $766.425 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $766.475 to $767.41 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $767.545 to $768.505 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $768.65 to $769.64 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $769.705 to $770.70 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $770.74 to $771.67 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $771.78 to $772.35 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $773.135 to $774.13 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $774.17 to $774.44 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares held of record by the Chan Zuckerberg Initiative Foundation ("CZI Foundation"). The reporting person is deemed to have voting and investment power over the shares held by CZI Foundation, but has no pecuniary interest in these shares.

The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.

/s/ Erin Guldiken, attorney-in-fact for Mark Zuckerberg


Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Class A Common Stock

Shares held of record by CZI Holdings, LLC ("CZI"). Mark Zuckerberg, Trustee of the Mark Zuckerberg Trust dated July 7, 2006 ("2006 Trust"), is the sole member of CZI. The reporting person is the sole trustee of the 2006 Trust and, therefore, is deemed to have sole voting and investment power over the securities held by CZI.

The sales reported were effected by CZI pursuant to the Rule 10b5-1 trading plan adopted by the reporting person on February 1, 2025.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $760.83 to $761.81 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $761.83 to $762.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $762.86 to $763.825 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $763.87 to $764.70 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $764.88 to $765.80 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $765.89 to $766.84 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $767.07 to $768.04 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $768.10 to $769.095 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $769.10 to $769.60 per share. The holder undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares held of record by the Chan Zuckerberg Initiative Foundation ("CZI Foundation"). The reporting person is deemed to have voting and investment power over the shares held by CZI Foundation, but has no pecuniary interest in these shares.

The Class B Common Stock is convertible into the issuer's Class A Common Stock on a 1-for-1 basis (a) at the holder's option or (b) upon certain transfers of such shares and has no expiration date.

Shares held of record by Mark Zuckerberg, Trustee of the 2006 Trust.

Shares held of record by Chan Zuckerberg Holdings, LLC ("CZ Holdings"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings.

Shares held of record by CZI Holdings I, LLC ("CZI I"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZI I.

Shares held of record by Chan Zuckerberg Holdings II, LLC ("CZ Holdings II"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings II.

Shares held of record by Chan Zuckerberg Holdings III, LLC ("CZ Holdings III"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings III.

Shares held of record by CZ Management, LLC ("CZ Management"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Management.

Shares held of record by Chan Zuckerberg Holdings IV, LLC ("CZ Holdings IV"), which is beneficially owned by the reporting person. The reporting person is deemed to have sole voting and investment power over the securities held by CZ Holdings IV.


By Kumar Haldea Revocable Trust, of which the Reporting Person is a co-trustee.

By Kumar Haldea Family Irrevocable Trust, of which the Reporting Person is a co-trustee.

This transaction was effected pursuant to a Rule 10b5-1 sales plan adopted by the Reporting Person on March 31, 2025.

Represents the weighted average sale price of the shares sold from $44.31 to $45.305 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Represents the weighted average sale price of the shares sold from $45.31 to $46.10 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Represents the weighted average sale price of the shares sold from $45.49 to $46.48 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.

Represents the weighted average sale price of the shares sold from $46.49 to $47.20 per share. The Reporting Person will provide, upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares sold at each separate price for all transactions within the range set forth in this footnote.


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 9, 2025.


Common Stock

Represents a buy and hold exercise by the reporting person of a stock option that was set to expire on September 29, 2025.

Includes 126,904 shares of common stock, par value $0.0001 per share ("Common Stock"), underlying restricted stock units ("RSUs") granted to the reporting person on May 20, 2025 pursuant to the Issuer's 2023 Incentive Plan. Such RSUs will vest in full, and an equal number of shares of Common Stock will be deliverable to the reporting person, immediately prior to the Issuer's 2026 Annual Meeting of Stockholders, subject to continued service through such vesting date.

The shares reported are owned by the SPLINTER ROBOOSTOFF REV TRUST UAD 1/23/97, for which the reporting person serves as Trustee and exercises investing authority over such shares.

The shares reported are owned by the AMANDA CHRISTINE SPLINTER 2012 IRREVOCABLE TRUST DTD 08/10/2012, for which the reporting person serves as Trustee and exercises investing authority over such shares.

The shares reported are owned by the ARCHIE DAVID ROBOOSTOFF 2012 IRREVOCABLE TRUST DTD 08/10/2012, for which the reporting person serves as Trustee and exercises investing authority over such shares.

The shares reported are owned by the JOSHUA MICHAEL SPLINTER 2012 IRREVOCABLE TRUST DTD 08/10/2012, for which the reporting person serves as Trustee and exercises investing authority over such shares.

The shares reported are owned by the KRISTA DIANE FENSKE 2012 IRREVOCABLE TRUST DTD 08/10/2012, for which the reporting person serves as Trustee and exercises investing authority over such shares.

The stock option was exercisable on July 31, 2019.

/s/ Bill Roeschlein, as attorney-in-fact


By John Freund Family Partnership IV, L.P

This transaction was executed in multiple trades at prices ranging from $15.80 USD to $16.3950 USD; the price reported above reflects the weighted average sale price. The Reporting Person undertakes to provide Issuer, any security holder of the Issuer, or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Shares held by John Freund Family Partnership IV, L.P. ("Family LP"). Reporting Person, a member of Issuer's board of directors, is a general partner of Family LP and may be deemed to have voting and investment power with respect to the securities held by Family LP. Reporting Person disclaims beneficial ownership of such securities, except to the extent of his pecuniary interest therein.

Includes 8,675 shares issuable on the settlement of restricted stock units granted to the Reporting Person. Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.

/s/ Michael A. Pisetsky, Attorney-in-Fact for John G. Freund


The sale reported on this Form 4 was effected pursuant to a 10b5-1 trading plan established by the Reporting Person on November 26, 2024.

The total securities beneficially owned includes shares of unvested restricted stock units.


Class A Common Stock

Class A Common Stock

Class A Common Stock

The sales reported in this Form 4 were effected pursuant to a 10b5-1 trading plan adopted by the Reporting Person on March 11, 2025 in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $91.30 to $91.41, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

The option was granted on April 28,2021, the Vesting Commencement Date ("VCD").  One forty-eighth of the shares subject to the original grant vest on each monthly anniversary thereafter subject to continued employment with the Issuer through the applicable vesting dates.

The option was granted on April 26,2022, the VCD. One forty-eighth of the shares subject to the original grant vest on each monthly anniversary thereafter subject to continued employment with the Issuer through the applicable vesting dates.

The option was granted on April 24, 2023, the VCD. One forty-eighth of the shares subject to the original grant vest on each monthly anniversary thereafter subject to continued employment with the Issuer through the applicable vesting dates.

/s/ Kelli Faerber, Attorney-in-Fact for Jay R. Grant


Shares held by the Crist Biorn Shepherd & Roskoph 401(k) Profit Sharing Plan FBO Kristofer Biorn. Reporting Person has sole voting and dispositive power with respect to such shares.

Shares held by the Biorn Family Trust of which the Reporting Person and his spouse are the trustees and may be deemed to share voting and dispositive power over such shares.


Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

Common Stock

The option was exercised, and a portion of the underlying shares were sold to cover the exercise price and estimated tax liability, pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024.

Includes 1.5215 shares acquired under a dividend reinvestment plan.

This transaction was executed in multiple trades at prices ranging from $319.49 to $320.48.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

This transaction was executed in multiple trades at prices ranging from $320.49 to $321.48.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

This transaction was executed in multiple trades at prices ranging from $321.49 to $322.48.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

This transaction was executed in multiple trades at prices ranging from $322.50 to $322.75.  The price reported above reflects the weighted average sale price.  The reporting person hereby undertakes to provide upon request to the SEC staff, the Issuer or a security holder of the Issuer full information regarding the number of shares and prices at which the transaction was effectuated.

This information is based on a plan statement dated June 30, 2025.

Option fully vested.

Exercise of Rule 16b-3 stock option pursuant to a Rule 10b5-1 Plan, which was adopted on October 24, 2024.

Original stock option grant vests in three annual installments beginning on the date listed in the "Date Exercisable" column.

1 for 1.

The restricted stock units vest three years from the grant date on the date listed above, assuming continued employment.

If the Company achieves certain goals over the 2023-2025 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

If the Company achieves certain goals over the 2024-2026 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

If the Company achieves certain goals over the 2025-2027 period, the performance units will vest and stock will be awarded. The target number of units that may be earned is reported above; the maximum amount is 200% of the number reported, subject to plan limits.

Payment will be made in accordance with the reporting person's deferral election, death, disability or termination of employment.

/s/ Ryan S. Lovitz under Power of Attorney for Nicholas T. Pinchuk


Common Stock

Common Stock

Common Stock

Reflects the most recent ESOP and 401(k) balance.

The restricted stock units will vest 1/3 on each of March 15, 2025, 2026 and 2027.

The restricted stock units will vest 1/3 on each of March 15, 2026, 2027 and 2028.

The options will vest 50% on each of February 28, 2024 and February 28, 2025.

/s/ Russell E. Ryba, Attorney-in-Fact for Sean P. Leuba


Shares were sold pursuant to a 10b5-1 Plan dated August 16, 2024.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.445 to $19.47 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

The reported price in Column 4 is a weighted average sale price. These shares were sold in multiple transactions at prices ranging from $18.49 to $18.92 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.


Common Stock

Includes a total of 27.3420 shares purchased under the Issuer Employee Stock Purchase Plan on March 31, 2025 and June 30, 2025.

Grant of option to buy 1,849 shares of Issuer common stock that vested on February 14, 2022.

Not applicable.

/s/ Lily J. Lu, Attorney-in-Fact for Andrew Emerson


Includes 24.8911 shares acquired on June 30, 2025 under the Microsoft Employee Stock Purchase Plan.

Benjamin O. Orndorff, Attorney-in-Fact for Bradford L. Smith


By Polster/Yamamoto Living Trust dtd 2/8/2021.


Common Stock

The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on May 8, 2025.

This transaction was executed in multiple trades at prices ranging from $30.23 to $31.31. This price reported in Column 4 reflects the weighted average purchase prices. The Reporting Person hereby undertakes to provide, upon written request, to the SEC staff, the Issuer, or a security holder of the Issuer, full information regarding the number of shares and prices at which the transaction were effected.

Includes 121,215 unvested restricted stock units granted pursuant to Issuer's 2016 Incentive Compensation Plan, with each unit representing the contingent right to receive one share of Issuer's common stock.


Since the date of the reporting person's last ownership report, he transferred 6,884 shares of SFNC common stock from one of his direct accounts to his ex-spouse pursuant to a domestic relations order.

/s/ Natalie Gassiott, attorney-in-fact for Russell William Teubner


Common Stock

Common Stock

Common Stock

/s/ Russell E. Ryba, Attorney-in-Fact for Rachele M. Lehr


Class A Common Stock

Each  performance stock unit represents the contingent right to receive one share of Fox Corporation's Class A Common Stock upon vesting.

The performance stock units, originally awarded in August 2022, were granted to the Reporting Person after the achievement of pre-determined performance measures over the three-year performance period and shall vest in shares of Fox Corporation's Class A Common Stock on August 15, 2025.

/s/ Laura A. Cleveland as Attorney-in-Fact for Keith Rupert Murdoch


Class A Common Stock

Class A  Common  Stock

Each restricted stock unit represents the contingent right to receive one share of Fox Corporation's Class A Common Stock upon vesting.

The restricted stock units will vest one-third on each of August 15, 2026, August 15, 2027 and August 15, 2028.

The performance stock options may vest and become exercisable on August 8, 2028, based on the attainment of a 15% increase in the price of Fox Corporation's Class A Common Stock over the exercise price for at least 30 consecutive calendar days during the period from the date of grant to August 8, 2028.

/s/ Laura A. Cleveland as Attorney-in-Fact for Adam G. Ciongoli


These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026.

Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

Shares are held for the benefit of The Kenneth W. O'Keefe Trust U/A/D 2/12/1997, of which the reporting person is both trustee and beneficiary.

By: /s/Adam Guttmann, as attorney in fact For: Kenneth O'Keefe


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.19 to $19.24, inclusive. The reporting person undertakes to provide to Grocery Outlet Holding Corp. (the "Issuer"), any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

/s/ Lauri Fischer, Lauri Fischer, attorney-in-fact


Class A Common Stock

Class A Common Stock

Class A  Common  Stock

The  restricted stock units and performance stock units each represent  the contingent right to receive one share of Fox Corporation's Class A Common Stock upon vesting.

/s/ Laura A. Cleveland as Attorney-in-Fact for Steven Tomsic


The Class C Google Stock Units (GSU) entitle the Reporting Person to receive one share of Alphabet Inc. Class C Capital Stock for each share underlying the GSU as GSU vest. 1/48th of GSUs vested on July 25, 2022 and an additional 1/48th of GSUs vests on the 25th day of each month thereafter, subject to continued service on the Board on the applicable vesting dates.

1/48th of GSU grant vested on July 25, 2023 and an additional 1/48th vests monthly on the 25th day of each month thereafter, subject to continued service on the Board on the applicable vesting dates.

1/48 of GSUs will vest on the 25th day of each month following the grant date for 31 months and on the 1st day of each month for the following 17 months, subject to continued service on the Board on the applicable vesting dates.

1/48 of GSUs will vest on the 25th day of each month following the grant date for 19 months and on the 1st day of each month for the following 29 months, subject to continued service on the Board on the applicable vesting dates.

All sale transactions reported in this Form 4 were effected pursuant to a Rule 10b5-1 Trading Plan adopted by the John L. Hennessy and Andrea J. Hennessy Revocable Trust UAD 10/22/93 on November 5, 2024.

/s/ Valentina Margulis, as Attorney-in-Fact for John L. Hennessy


Class A Common Stock

Class A  Common  Stock

Class A  Common  Stock

/s/ Laura A. Cleveland as Attorney-in-Fact for John Nallen


Class A Common Stock

Class A Common Stock

Class A  Common  Stock

The performance stock units originally awarded in August 2022, were granted to the Reporting Person after the achievement of pre-determined performance measures over the three-year performance period and shall vest in shares of Fox Corporation's Class A Common Stock on August 15, 2025.

/s/ Laura A. Cleveland as Attorney-in-Fact for Lachlan K. Murdoch


The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $134.551 to $134.58, inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.

Balance in the Abbott Laboratories Stock Retirement Trust as of August 8, 2025.

/s/ Philip P. Boudreau by Jessica H. Paik, Attorney-in-Fact


The reported sales were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 24, 2024.

Certain of these shares are represented by restricted stock units ("RSUs"). Each RSU represents the Reporting Person's right to receive one share of Common Stock of the Issuer subject to the applicable vesting schedule and the Reporting Person's continuous service through each such date.


The sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 trading plan.


Common Stock

Represents 26,743 stock options granted on August 7, 2025, which vest in three equal installments on June 30 of each of 2026, 2027 and 2028, subject to the reporting person's completion of each
12 month period of service through such vesting dates. Does not include up to an additional 13,205 unvested PSUs at target achievement (or up to an additional 26,410 unvested PSUs at maximum
achievement) which are eligible to vest upon the achievement of certain performance-based vesting conditions.

The reporting person's title is EVP, Chief Merchandising Officer.


Class A Common Stock

Reflects shares sold to cover taxes upon the vesting of Restricted Stock Units on August 8, 2025, pursuant to a Rule 10b5-1 instruction letter adopted by the Reporting Person on March 3, 2023 related solely to tax obligations associated with awards received in connection with Bandwidth Inc. (the "Company") equity compensation programs.

The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $13.21 to $13.39. The reporting person undertakes to provide the Company, any security holder of the Company, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.

Each Restricted Stock Unit represents a contingent right to receive one share of the Company's Class A Common Stock.

On August 8, 2022, the Reporting Person was granted 29,481 Restricted Stock Units, which vest in four equal annual installments beginning on August 8, 2023.

/s/ Leah Webb, Attorney-in-Fact for Devesh Agarwal


These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026.

Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

By: /s/Adam Guttmann, as attorney in fact For: Jennifer Cook


Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $7.38 to $7.45, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range.

Represents the weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $7.91 to $8.01, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the aforementioned range.

By:  /s/ Kelly M. Kaiser, as attorney-in-fact for Michael Osanloo


MacKenzie Realty Capital Inc. Common Stock

MacKenzie Real Estate Advisers, LP ("MREA") acquired shares of MacKenzie Realty Capital, Inc. ("MRC"). The filer owns an interest in MREA and therefore could be deemed to beneficially own the MRC shares acquired by MREA, but disclaims beneficial ownership of the securities referred to herein except to the extent of the filer's pecuniary interest in such securities.

MPF Successors, LP ("MPF") acquired shares of MacKenzie Realty Capital, Inc. ("MRC"). The filer owns an interest in MPF and therefore could be deemed to beneficially own the MRC shares acquired by MPF, but disclaims beneficial ownership of the securities referred to herein except to the extent of the filer's pecuniary interest in such securities.


By: /s/Adam Guttmann, as attorney in fact For: Patrick Enright


These restricted stock units ("RSUs") vest on the earlier of (a) the first anniversary of the grant date of such award or (b) the date immediately preceding the next annual meeting of Companys stockholders, subject to the non-employee directors continued service through the applicable vesting date.

The amount of the reported securities gives effect to a reduction in shares of Common Stock underlying RSUs that were held directly by the Reporting Person for the benefit of GreyLion (which shares were received upon vesting and transferred to GreyLion), and the corresponding increase in shares held indirectly through GreyLion. The reporting person disclaims beneficial ownership except to the extent of his pecuniary interest therein, which interest is unchanged by the transfer.

Includes 5,785,182 shares held by PWP Growth Equity Fund II LP and 1,665,148 shares held by PWP Growth Equity Fund II B LP (collectively, the "Funds") for which  investing, management and voting control is exercised by GreyLion Partners LP (together with its affiliates, "GreyLion Partners"). David Ferguson and the Reporting Person are members of the GreyLion Partners investment committee and control voting and investment decisions related to the shares reported herein.


By: /s/Adam Guttmann, as attorney in fact For: Laura Hamill


Common Stock

This transaction represents shares withheld by the issuer to satisfy its minimum tax withholding obligation in connection with the vesting of restricted shares previously granted to the reporting person.

The partnership units are designated LTIP Series D Units, which is a class of partnership interests in Healthcare Realty Holdings, L.P., a Delaware limited partnership ("HR Holdings"), the operating subsidiary of the Issuer. The units were issued upon the vesting of performance based LTIP Series C Units, previously issued to the reporting person.

The partnership units are intended to qualify as profits interests for U.S. federal income tax purposes.  Upon achieving equivalent capital account balance per unit, the units are convertible into common partnership interests in HR Holdings and then may be converted into common stock of the Issuer on a one-for-one basis. The partnership units have no expiration date.

/s/ Andrew E. Loope as power of attorney


COMMON SHARES

Upon redemption, Deferred Share Units entitle the reporting person to receive a lump sum cash payment in an amount equal to the fair market value of the common shares of Cronos Group Inc. (the "Company") on the date of redemption.

Vested Deferred Share Units are mandatorily redeemed by the Company on the first trading day after the reporting person ceases to be a director of the Company.

/s/ Aaron Werner, as attorney-in-fact for James D. Rudyk


/s/ Jeri Bluth, as attorney-in-fact for Glen Fuller


By: /s/Adam Guttmann, as attorney in fact For: Patrick Kennedy


COMMON SHARES

/s/ Aaron Werner, as attorney-in-fact for Jason M. Adler


By: /s/Adam Guttmann, as attorney in fact For: Heather McSharry


Shares held by The Hendrickson Family Trust U/A 11/17/92, of which the Reporting Person and spouse are the trustees with shared voting and dispositive power.


/s/ Jeri Bluth, as attorney-in-fact for Charles E. Patterson II


By: /s/Adam Guttmann, as attorney in fact For: Anne O'Riordan


COMMON SHARES

/s/ Ryan Morgan, as attorney-in-fact for Murray R. Garnick


Shares beneficially owned by NORBERT G. RIEDEL 2023 TRUST, an entity owned and controlled by the reporting person and his immediate family.

By: /s/Adam Guttmann, as attorney in fact For: Norbert Riedel


Class B Common Stock

The shares identified in Table I represent shares of Class B common stock of Paramount Global to which the Reporting Person became entitled, upon vesting of Restricted Share Units ("RSUs") identified in Table II, immediately prior to the closing of the Transactions (as defined below), but which have not been received because the director previously elected to defer receipt.

Includes 82,132 shares of Paramount Global Class B common stock underlying vested RSUs for which the Reporting Person previously elected to defer receipt.

On August 7, 2025, the previously announced transactions contemplated by the transaction agreement, dated as of July 7, 2024 ("Transaction Agreement"), by and among: Skydance Media, LLC ("Skydance"), Paramount Global, Paramount Skydance Corporation (f/k/a New Pluto Global, Inc.) ("Paramount Skydance"), and the other parties thereto were completed. Pursuant to the terms of the Transaction Agreement, in a series of transactions, each of Paramount Global and Skydance merged into subsidiaries of Paramount Skydance (the "Transactions").

Represents the disposition of shares of Paramount Global common stock and the acquisition of shares of Paramount Skydance common stock (including shares underlying vested RSUs assumed by Paramount Skydance for which the Reporting Person previously elected to defer receipt).  Pursuant to the terms of the Transaction Agreement, each share of Paramount Global Class B common stock converted into the right to receive one share of Paramount Skydance Class B common stock, or at the election of the holder of such share, cash in the amount of $15.00 per share, subject to pro ration as set forth in the Transaction Agreement.

Represents the number of shares of Paramount Skydance common stock beneficially owned following the transactions described herein.

/s/ Caryn K. Groce, Attorney-in-Fact for Linda M. Griego


MacKenzie Real Estate Advisers, LP ("MREA") acquired shares of MacKenzie Realty Capital, Inc. ("MRC"). The filer owns an interest in MREA and therefore could be deemed to beneficially own the MRC shares acquired by MREA, but disclaims beneficial ownership of the securities referred to herein except to the extent of the filer's pecuniary interest in such securities.

MPF Successors, LP ("MPF") acquired shares of MacKenzie Realty Capital, Inc. ("MRC"). The filer owns an interest in MPF and therefore could be deemed to beneficially own the MRC shares acquired by MPF, but disclaims beneficial ownership of the securities referred to herein except to the extent of the filer's pecuniary interest in such securities.

/s/ Jeri Bluth, as attorney-in-fact for Christine Simpson


These restricted stock units are granted pursuant to the Issuer's 2007 Amended and Restated Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in full on July 24, 2026.

Shares sold to satisfy tax obligations arising out of the vesting of previously granted restricted stock units.

By: /s/Adam Guttmann, as attorney in fact For: Mark D. Smith


The price reported in Column 4 is a weighted average price. These shares were purchased in transactions at prices ranging from $42.4450 to $42.4796, inclusive. The Reporting Person undertakes to
provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate
price within the ranges set forth in this footnote.

Chief Information Officer and Chief Transformation Officer

/s/ Brian Golper, as Attorney-in-Fact for Sudarsan V Thattai


By: /s/Adam Guttmann, as attorney in fact For: Rick E Winningham


Shares owned directly by Ancora Catalyst. Mr. DiSanto, solely by virtue of his position as the Chairman and Chief Executive Officer of Ancora Holdings, the sole member of Ancora Alternatives, the General Partner of Ancora Catalyst, may be deemed to beneficially own the shares owned directly by Ancora Catalyst, for purposes of Section 16. Mr.DiSanto expressly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.

Shares owned directly by Ancora Merlin. Mr. DiSanto, solely by virtue of his position as the Chairman and Chief Executive Officer of Ancora Holdings, the sole member of Ancora Alternatives, the General Partner of Ancora Merlin, may be deemed to beneficially own the shares owned directly by Ancora Merlin, for purposes of Section16. Mr.DiSanto expressly disclaims beneficial ownership of such shares except to the extent of his pecuniary interest therein.


Shares beneficially owned by Nerano Pharma Limited, an entity owned and controlled by the reporting person and his immediate family.

By: /s/Adam Guttmann, as attorney in fact For: Seamus Mulligan


/s/ Jeri Bluth, as attorney-in-fact for Angche Sherpa


These restricted stock units are granted pursuant to the Issuer's 2011 Equity Incentive Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. These units vest in equal annual installments over four years measured from the vesting commencement date of September, 2025, with 1/4th vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent three years.

The Reporting Person acquired 166 ordinary shares under a Section 423 Employee Stock Purchase Plan on May 30, 2025.

By: /s/Adam Guttmann, as attorney in fact For: Renee D Gala


Warrants to purchase Class A Common Stock

Class A Common Stock

Reflects the exercise of 1,920,000 warrants to purchase shares of Class A common stock of Utz Brands, Inc. ("Issuer") on a cashless basis pursuant to the Warrant Agreement, dated as of October 4, 2018  (the "Warrant Agreement"), by and between Collier Creek Holdings ("Collier Creek") and Continental Stock Transfer & Trust Company ("CST"), as assumed by the Issuer pursuant to that certain Assignment and Assumption Agreement, dated as of February 22, 2022, by and among the Issuer, CST, Equinity Trust Company ("Equinity") and the Consenting Holders (as defined therein). The number of shares of Class A common stock issuable upon exercise of the warrants was determined in accordance with section 3.3.1(c) of the Warrant Agreement.

These securities include shares of Class A Common Stock that are held by Jason K. Giordano together with his spouse.

Reflects the shares of Class A common stock "withheld" in connection with the cashless exercise. Pursuant to Section 3.3.1(c) of the Warrant Agreement, the price was calculated as the average last reported sale price of the shares for the ten trading days ending on the third trading day prior to the date on which notice of exercise of the private placement warrant was sent to the warrant agent.

The warrants are exercisable at any time and expire on August 28, 2025 or earlier upon redemption or the liquidation of the Issuer.

/s/ Theresa R. Shea, as attorney-in-fact for Jason K. Giordano